Anavex Life Sciences Corp (AVXL): Catalysts to Drive Value The company...

Reply Private New

Replies (4) Next 10 Prev Next

Send PM Follow Ignore

Followers	139
Posts	23290
Boards Moderated	0
Alias Born	04/08/2004

georgejjl

Re: None

Tuesday, 11/16/2021 2:41:34 PM

Tuesday, November 16, 2021 2:41:34 PM

Catalysts to Drive Value

The company has multiple clinical milestones

> Top-line data AVATAR: Potentially pivotal Phase 2/3 adult RTT clinical trial – expected 2H 2021

> Top-line data Phase 1 ANAVEX®3-71 clinical trial – expected 2H 2021

>Top-line data EXCELLENCE: Potentially pivotal Phase 2/3 pediatric RTT clinical trial – expected 1H 2022

>Top-line data ANAVEX®2-73-AD-004: Potentially pivotal Phase 2b/3 AD clinical trial – expected 2H 2022

>Initiation of ANAVEX®2-73 imaging-focused Parkinson’s disease clinical trial – expected 2021

>Pipeline expansion opportunities for ANAVEX®2-73

>Initiation of potentially pivotal Phase 2/3 Fragile X clinical trial – expected 2021

>Initiation of potentially pivotal Phase 2/3 clinical trial for the treatment of a new, rare disease
indication – expected 2021

Good luck and GOD bless,